NPI registry status
Active
2026 NPPES data Endocrinology, Diabetes & Metabolism Physician NPI 1982633624 MD
Verify on CMS → Matthew Corcoran, MD
Endocrinology, Diabetes & Metabolism Physician in Egg Harbor Township, New Jersey.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 8,078 in Endocrinology, Diabetes & Metabolism Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
6K
Medicare Part D claims · 667 beneficiaries · Endocrinology, Diabetes & Metabolism Physician avg: 3K
Generic prescribing
33%
generic claims · 58% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$42.6K
133 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Matthew Corcoran, MD filed 6,034 Medicare Part D claims in 2024 as an Endocrinology, Diabetes & Metabolism Physician in Egg Harbor Township, New Jersey, prescribing 33% generic.
- 6K
- Part D claims, 2024
- 33%
- generic prescribing
- Likely
- board-certified (heuristic)
- ≥95th
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Matthew Corcoran, MD
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1982633624), first enumerated 07/03/2006.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 6,034 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Hospital affiliations
1 CMS Care Compare hospital affiliation on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- Reported
Industry payment transparency
$42.6K in reported industry payments (133 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1982633624 · Endocrinology, Diabetes & Metabolism Physician
NPI-10 · ENUM-LEGACY · TAX-MID · RX-MID · BOOK-THIN · PHOTO-ENUM
- NPI-10 1982633624
- ENUM-LEGACY 2006
- TAX-MID 8K Endocrinology, Diabetes
- RX-MID 6,034
- BOOK-THIN 330 in New Jersey
- PHOTO-ENUM Eloy Ituarte · 2006
Matthew Corcoran, MD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
6,034 ≥ 95th percentile 95% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
✓
Board certification likely (heuristic, not verified)
Matthew Corcoran, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Matthew Corcoran, MD?
Quality data not reportedPrimary specialty
Endocrinology, Diabetes & Metabolism Physician
Medicare Part D claims
6,034 120% vs specialty avg
Specialty distribution in New Jersey
How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among New Jersey providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Endocrinology, Diabetes & Metabolism Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1982633624 |
|---|---|
| Specialty | Endocrinology, Diabetes & Metabolism Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 07/03/2006 |
Hospital and facility affiliations
Facilities where Matthew Corcoran, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Shore Specialty Consultants
Somers Point, NJ
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Matthew Corcoran, MD. Source: openpaymentsdata.cms.gov.
Total received
$42.6K
Largest payer
SANOFI-AVENTIS U.S. LLC
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Brand-heavy
Matthew Corcoran, MD - brand share 58.0%
Endocrinology, Diabetes & Metabolism Physician average
58% brand-name claims vs 33% generic, on 6,034 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
6,034
Total Claims
$3.9M
Total Drug Cost
667
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 14,745.667
- Total Day Supply
- 437,183
- Brand vs Generic
- 58% brand / 33% generic
- Brand Drug Cost
- $3.6M
- Generic Drug Cost
- $44K
- Antibiotic Claims
- 48
Patient Demographics
- Average Patient Age
- 73.5 years
- Avg HCC Risk Score
- 1.49
- Gender Split
- 59% female / 41% male
- Age Distribution
- <65: 51, 65-74: 321, 75-84: 242, 85+: 53
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Matthew Corcoran, MD prescribes most
Top Medicare Part D drugs by claim count, 2024
- Ozempic
Ozempic
568 claims
- Synthroid
Synthroid
526 claims
- Levothyroxine Sodium
Levothyroxine Sodium
457 claims
- Mounjaro
Mounjaro
310 claims
- Metformin Hcl
Metformin Hcl
296 claims
- Metformin Hcl Er
Metformin Hcl Er
268 claims
- Tresiba Flextouch …
Tresiba Flextouch U-100
233 claims
- Jardiance 202
Jardiance
202 claims
| Drug | Claims |
|---|---|
| Ozempic Semaglutide | 568 |
| Synthroid Levothyroxine Sodium | 526 |
| Levothyroxine Sodium | 457 |
| Mounjaro Tirzepatide | 310 |
| Metformin Hcl | 296 |
| Metformin Hcl Er Metformin Hcl | 268 |
| Tresiba Flextouch U-100 Insulin Degludec | 233 |
| Jardiance Empagliflozin | 202 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 191 |
| Glipizide Er Glipizide | 189 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
More Endocrinology, Diabetes & Metabolism Physician in NJ →
All providers in New Jersey →
Compare specialties →
Endocrinology, Diabetes & Metabolism Physician Overview
How Matthew Corcoran, MD fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.
8,078
Endocrinology, Diabetes & Metabolism Physician Providers in US
54
States with Endocrinology, Diabetes & Metabolism Physician
2,739
Avg Claims per Provider
Matthew Corcoran, MD's 6,034 claims are above the specialty average of 2,739.
Nationwide Endocrinology, Diabetes & Metabolism Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Corcoran, both outside New Jersey so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2006)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Endocrinology, Diabetes & Metabolism Physician Providers in New Jersey
Other clinicians with the same primary specialty enrolled in New Jersey, drawn from the same CMS NPPES roster as Corcoran.
One of 330 Endocrinology, Diabetes & Metabolism Physician providers enrolled in New Jersey, 5 are shown here.
Dr. Alice Abraham
M.D.
Englewood, NJ
Dr. Sonoo Advani
M.D.
West Orange, NJ
Dr. Karen Agersborg
DO
Cape May Court House, NJ
Dr. Richard Agrin
MD
New Brunswick, NJ
Dr. Sana Ahsun
MD
Piscataway, NJ
Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Matthew Corcoran, MD's specialty? ▼
Matthew Corcoran, MD specializes in Endocrinology, Diabetes & Metabolism Physician and practices in Egg Harbor Township, New Jersey. Credentials: MD.
How much does Matthew Corcoran, MD prescribe under Medicare Part D? ▼
In 2024, Matthew Corcoran, MD wrote 6,034 Medicare Part D claims totaling $3.9M in drug costs for 667 beneficiaries.
Where is Matthew Corcoran, MD located? ▼
Matthew Corcoran, MD is located at 2500 ENGLISH CREEK AVE, Egg Harbor Township, NJ, 08234. Phone: (609) 407-2277.
What is Matthew Corcoran, MD's NPI number? ▼
Matthew Corcoran, MD's National Provider Identifier (NPI) is 1982633624, issued on 07/03/2006.
Does Matthew Corcoran, MD prescribe more brand-name or generic drugs? ▼
Matthew Corcoran, MD's prescribing is 58% brand-name and 33% generic drugs by claim count, with $3.6M in brand drug costs.
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US? ▼
There are 8,078 Endocrinology, Diabetes & Metabolism Physician providers across 54 states in the US. The average Endocrinology, Diabetes & Metabolism Physician provider writes 2,739 Medicare Part D claims per year.
What drugs does Matthew Corcoran, MD prescribe most often? ▼
Based on 2024 Medicare Part D data, Matthew Corcoran, MD's most frequently prescribed drugs include Ozempic, Synthroid, Levothyroxine Sodium. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Matthew Corcoran, MD accept Medicare? ▼
Matthew Corcoran, MD appears in CMS Medicare data with 6,034 Part D claims and 667 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Matthew Corcoran, MD's credentials? ▼
Matthew Corcoran, MD's NPI is 1982633624 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.